Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18047919rdf:typepubmed:Citationlld:pubmed
pubmed-article:18047919lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18047919lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:18047919lifeskim:mentionsumls-concept:C0948265lld:lifeskim
pubmed-article:18047919lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:18047919lifeskim:mentionsumls-concept:C2347946lld:lifeskim
pubmed-article:18047919lifeskim:mentionsumls-concept:C0857121lld:lifeskim
pubmed-article:18047919pubmed:issue12lld:pubmed
pubmed-article:18047919pubmed:dateCreated2007-11-30lld:pubmed
pubmed-article:18047919pubmed:abstractTextThe prognostic impact of metabolic syndrome (MetS) in the hypertensive population at low-medium risk is unknown. In this study, we evaluated the prognostic relevance of MetS in hypertensive patients at low-medium risk.lld:pubmed
pubmed-article:18047919pubmed:languageenglld:pubmed
pubmed-article:18047919pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18047919pubmed:citationSubsetIMlld:pubmed
pubmed-article:18047919pubmed:statusMEDLINElld:pubmed
pubmed-article:18047919pubmed:monthDeclld:pubmed
pubmed-article:18047919pubmed:issn0895-7061lld:pubmed
pubmed-article:18047919pubmed:authorpubmed-author:LapennaDomeni...lld:pubmed
pubmed-article:18047919pubmed:authorpubmed-author:PierdomenicoS...lld:pubmed
pubmed-article:18047919pubmed:authorpubmed-author:CuccurulloFra...lld:pubmed
pubmed-article:18047919pubmed:authorpubmed-author:MezzettiAndre...lld:pubmed
pubmed-article:18047919pubmed:authorpubmed-author:NeriMatteoMlld:pubmed
pubmed-article:18047919pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:18047919pubmed:authorpubmed-author:CaldarellaMar...lld:pubmed
pubmed-article:18047919pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:18047919pubmed:issnTypePrintlld:pubmed
pubmed-article:18047919pubmed:volume20lld:pubmed
pubmed-article:18047919pubmed:ownerNLMlld:pubmed
pubmed-article:18047919pubmed:authorsCompleteYlld:pubmed
pubmed-article:18047919pubmed:pagination1291-6lld:pubmed
pubmed-article:18047919pubmed:dateRevised2009-2-24lld:pubmed
pubmed-article:18047919pubmed:meshHeadingpubmed-meshheading:18047919...lld:pubmed
pubmed-article:18047919pubmed:meshHeadingpubmed-meshheading:18047919...lld:pubmed
pubmed-article:18047919pubmed:meshHeadingpubmed-meshheading:18047919...lld:pubmed
pubmed-article:18047919pubmed:meshHeadingpubmed-meshheading:18047919...lld:pubmed
pubmed-article:18047919pubmed:meshHeadingpubmed-meshheading:18047919...lld:pubmed
pubmed-article:18047919pubmed:meshHeadingpubmed-meshheading:18047919...lld:pubmed
pubmed-article:18047919pubmed:meshHeadingpubmed-meshheading:18047919...lld:pubmed
pubmed-article:18047919pubmed:meshHeadingpubmed-meshheading:18047919...lld:pubmed
pubmed-article:18047919pubmed:year2007lld:pubmed
pubmed-article:18047919pubmed:articleTitlePrognostic relevance of metabolic syndrome in hypertensive patients at low-to-medium risk.lld:pubmed
pubmed-article:18047919pubmed:affiliationDipartimento di Medicina e Scienze dell'Invecchiamento, Università Gabriele d'Annunzio, Chieti, Italy. pierdomenico@unich.itlld:pubmed
pubmed-article:18047919pubmed:publicationTypeJournal Articlelld:pubmed